Selenium-Dependent Glutathione Peroxidases During Tumor Development

Area of Science:

• Biochemistry
• Oncology
• Nutritional Science

Background:

• Five of eight human glutathione peroxidases (GPx) are selenoproteins, requiring selenium (Se) for expression.
• Se-dependent GPx levels are typically downregulated in tumor cells, with notable upregulation of GPx2.
• The predictive value of GPx expression profiles for tumor development and patient survival remains debated.

Purpose of the Study:

• To discuss the multifaceted roles of individual Se-dependent GPx isoforms in tumorigenesis.
• To explore the conflicting evidence regarding GPx functions in cancer, considering both anti- and procarcinogenic mechanisms.
• To analyze how GPx-mediated reduction of hydroperoxides impacts DNA integrity, cellular signaling, and cell fate in the context of cancer.

Main Methods:

• Literature review and synthesis of existing in vitro and in vivo studies.
• Analysis of expression profiles of GPx isoforms in tumor cells.
• Discussion of GPx functions including hydroperoxide reduction, modulation of redox-sensitive pathways, and initiation of cell death.

Main Results:

• Se-dependent GPx expression is linked to selenium availability.
• GPx isoforms exhibit differential expression patterns in tumors (e.g., GPx2 upregulation).
• GPx activities can lead to DNA protection, altered cell signaling, or cell death, with context-dependent outcomes.

Conclusions:

• Se-dependent GPx isoforms have complex and often opposing roles in cancer development and progression.
• Understanding the specific functions of each GPx isoform is crucial for elucidating their net effect in tumorigenesis.
• Further research is needed to reconcile the anti- and procarcinogenic evidence and clarify the precise contribution of GPx to cancer.